abstract |
The present invention relates to a pharmaceutical composition comprising placenta-derived stem cells as an active ingredient, and has anti-aging and anti-cell death effects, and particularly relates to a pharmaceutical composition comprising vitamin D receptor (VDR, vitamin D-receptor) expression level. |